ALAB Insider Transfers 480,668 Shares into Estate Planning Trusts
Rhea-AI Filing Summary
Astera Labs insider transfer and holdings update. Director and President/COO Gajendra Sanjay reported transactions on 09/02/2025 moving 480,668 shares of common stock. The filing shows a corresponding reduction in directly held shares to 1,690,209 and an increase in indirectly beneficially owned shares to 6,006,213 held by three estate planning trusts. The Form 4 states the 480,668-share transfers to Trust 1 were for $0 and that Trusts 1–3 each hold 695,000 shares as described; the reporting person disclaims beneficial ownership of trust-held shares except for any pecuniary interest. The filing was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider moved shares into estate-planning trusts; direct holdings decreased while indirect holdings rose, per Form 4.
The Form 4 documents non-sales transfers of 480,668 shares on 09/02/2025 to an estate planning trust for no consideration, reducing direct ownership to 1,690,209 shares while reporting 6,006,213 shares indirectly owned across three trusts. This is a non-derivative securities transfer, not a market sale, and the filing includes standard disclaimers that the reporting person disclaims beneficial ownership of trust-held shares except to the extent of any pecuniary interest. For governance monitoring, the filing updates insider ownership figures and beneficial ownership structure without indicating a change in voting control disclosed in the form.
TL;DR: Filing documents a Section 16 change of beneficial ownership via trust transfers; disclosure complies with Form 4 reporting.
The report lists code G(1) transactions indicating transfers into a trust in which the reporting person is trustee. The Form 4 includes specific post-transaction balances: direct ownership of 1,690,209 shares and indirect ownership of 6,006,213 shares. The signature by an attorney-in-fact is provided with date. From a compliance standpoint, the form contains the required transaction codes, quantities, and explanatory remarks detailing trust ownership and disclaimers, fulfilling the reporting obligations reflected in the filing text.
FAQ
What transactions did Gajendra Sanjay report on Form 4 for ALAB?
How many ALAB shares does the reporting person directly and indirectly own after the transaction?
Were the transferred shares sold or transferred for consideration?
What trusts are referenced in the filing?
Who signed the Form 4 and when?